Anyone using 'good guy' SaaS pricing?

Yes—people use “good guy” SaaS pricing, and it can work in medtech. But in hospitals and regulated clinical workflows, it only works when it’s structured (clear value metric, clear boundaries, and a path to sustainable pricing). Otherwise it turns into “cheap forever,” which procurement will happily accept and your runway won’t.

What “good guy” SaaS pricing actually means (and why medtech founders reach for it)

“Good guy pricing” usually means one or more of these:

• Transparent, simple pricing (no “call for quote,” no hidden modules).
• Discounts framed as fairness (e.g., lower rates for safety-net hospitals, rural sites, trainees, research use).
• Risk-reversal (pilot pricing, opt-out clauses, performance guarantees).
• Non-extractive terms (no auto-renew traps, no punitive overage fees, easy data export).

In medtech, founders often choose this because:

• Clinicians distrust vendors who feel “salesy.”
• Procurement cycles are slow; goodwill helps you survive the first 6–18 months of selling.
• Early evidence generation (IRB studies, retrospective validation, prospective pilots) benefits from low-friction access.

The trap: hospitals don’t reward “nice.” They reward risk reduction, budget fit, and compliance. If your pricing isn’t mapped to those, “good guy” becomes “not taken seriously.”

When “good guy” pricing works (and when it backfires) in hospital buying

Works best when you’re early and need proof

It works when your primary goal is evidence and reference sites, not near-term margin. Examples:

• IRB-backed evaluation access: discounted or free for a defined study period, with clear deliverables (usage, outcomes, workflow metrics).
• Time-boxed pilots: a 60–120 day pilot fee that converts to an annual contract if predefined success criteria are met.
• Department-level land-and-expand: start with one service line (e.g., cardiology) with a fair entry price, then expand to enterprise after value is proven.

Backfires when procurement anchors you permanently

Hospital procurement teams anchor hard. If your first contract is “too nice,” it becomes the precedent for renewals and for other hospitals (“Site A pays X, match it.”). It also creates internal skepticism: “If it’s that cheap, is it real clinical-grade software?”

It also backfires when your product touches regulated claims. If you’re making diagnostic/therapeutic claims, your FDA pathway (often 510(k), De Novo, or PMA depending on risk and predicate availability) and your quality system obligations increase your cost base. “Good guy” pricing must still cover:

• Security/compliance (SOC 2, HIPAA controls, vendor risk assessments)
• Clinical safety work (post-market monitoring, complaint handling)
• Implementation (EHR integration, SSO, training)

3 pricing models that feel “good” but stay financially sane

The key is to be generous on terms and risk, not permanently generous on unit economics. (Unit economics = revenue and costs per customer/unit, e.g., per site per year.)

1) “Fair pilot” + pre-priced conversion

Structure:

• Pilot fee: small, fixed amount that covers onboarding and support.
• Success criteria: agreed metrics (time saved, reduced no-shows, fewer readmissions, improved documentation completeness—choose what you can measure).
• Conversion price: written into the pilot agreement (no surprise quote later).

Why it works in medtech: it aligns with how clinical champions operate (prove it first) and how procurement thinks (reduce risk, then commit).

2) Sliding scale by hospital type (but with published rules)

If you want to support safety-net/rural hospitals, do it with a policy, not ad hoc discounts. Example policy dimensions:

• Hospital classification (critical access, community, academic)
• Bed count bands
• Scope (single department vs enterprise)

Important: publish the bands internally and keep them consistent. “Good guy” becomes “predictable vendor,” which procurement actually likes.

3) Value-metric pricing that matches clinical operations

Instead of per-seat (which punishes adoption), consider metrics that map to operational value:

• Per facility / per site (common for hospital software; simplest for procurement)
• Per covered bed (aligns with scale)
• Per study / per procedure (fits imaging, diagnostics workflows)
• Per member per month (more common in payer/provider risk models; less common for acute care tools)

“Good guy” twist: include generous minimums or waived overages during ramp-up, then enforce boundaries once usage stabilizes.

How to avoid underpricing: set floors, fences, and a story procurement can repeat

Hospitals buy with committees. Your champion needs a simple narrative they can repeat to IT, compliance, finance, and procurement.

Set a price floor (your non-negotiable minimum)

Your floor should cover:

• Customer success/support time
• Hosting + security overhead
• Implementation (especially EHR integration)
• Regulatory/compliance burden (varies by product and claims)

If you can’t articulate your floor, you’ll negotiate against yourself.

Use “fences” so discounts don’t leak

A fence is a rule that limits who gets the deal. Examples:

• Time fence: discount applies only for year 1, then steps up.
• Scope fence: discount applies only to one department or one site.
• Evidence fence: discount tied to participation in a study, case report, or reference call (ensure compliance with hospital policies).

Make the “good” part about risk and ethics, not cheapness

In medtech, “good guy” can be:

• Data rights clarity: who owns derived data, how exports work, what happens at termination.
• Security transparency: straightforward answers for vendor risk assessments.
• Clinical governance: clear labeling, intended use, and if relevant, your FDA status/pathway (e.g., 510(k) clearance vs De Novo vs PMA) without overclaiming.

This builds trust without forcing you into unsustainable pricing.

Medtech-specific realities: reimbursement, CPT, and “who pays”

Pricing is easier when you know the economic buyer:

• Hospital operations (quality, throughput, staffing): they pay if you reduce cost or risk.
• Revenue cycle: they pay if you improve coding/documentation and collections (be careful—don’t promise reimbursement outcomes you can’t support).
• Clinician department: they can fund smaller tools, but budgets are limited and renewals are fragile.

If your product depends on reimbursement (e.g., remote monitoring, diagnostics workflows), you must understand the relevant CPT codes and coverage policies. Don’t build a pricing story that assumes reimbursement will “just happen.” Coverage and payment vary by payer, setting, and documentation.

If you’re doing clinical studies, align pricing with IRB realities: research use may require separate agreements, data handling terms, and timelines that don’t match commercial procurement.

What to do next

1. Write your pricing one-pager: value metric, pilot terms, conversion price, and discount policy (with fences). Keep it to one page.
2. Define your “floor” in a simple spreadsheet: minimum annual price that covers support, hosting, implementation, and compliance overhead.
3. Run 5 procurement-style objections (security review, integration cost, auto-renew terms, data export, budget cycle) and pre-answer them in your contract language.
4. Choose one “good guy” lever (risk-reversal pilot, sliding scale, or transparent value metric) and implement it consistently for the next 10 deals.

If you want feedback on whether your pricing sounds credible to a hospital buyer (and not just “cheap”), run it through /roast or compare your positioning against alternatives in /Competitor_study.